University venture fund Osage University Partners backs Sideris Pharmaceuticals in $32m series A.

University of Florida spin-out Sideris Pharmaceuticals has completed a $32m series A round, led by MPM Capital.

Joining the life science-focused venture firm in participation were Hatteras Venture Partners and Osage University Partners, a venture fund which represents over 60 US universities and research institutes.

The life sciences firm was spun out from Florida earlier in the year, supported by a seed round worth $599,000. It is developing therapeutics for the treatment of transfusion-related iron overload with its lead asset…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?